PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 3 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 7.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,557,982 | – | 25,112,000 | – | 22.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PenderFund Capital Management Ltd. | 20,060,000 | $23,311,000 | 5.66% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 44,492,000 | $39,153,000 | 1.56% |
| UBS OCONNOR LLC | 26,000,000 | $23,448,000,000 | 0.34% |
| Saltoro Capital, LP | 750,000 | $678,000 | 0.17% |
| AQR Arbitrage LLC | 3,050,000 | $2,758,000 | 0.10% |
| WATER ISLAND CAPITAL LLC | 1,500,000 | $1,371,000 | 0.08% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,448,000 | $3,103,000 | 0.07% |
| OAKTREE CAPITAL MANAGEMENT LP | 5,780,000 | $5,227,000 | 0.07% |
| Teton Advisors, Inc. | 400,000 | $358,000 | 0.05% |
| MACQUARIE GROUP LTD | 8,175,000 | $7,393,000 | 0.01% |